Head-to-head comparisons of medication uses, side effects, warnings, and more.
Key takeaways
Prolia (denosumab) and Tymlos (abaloparatide) are both medications used to treat osteoporosis, but they work in different ways and have different dosing schedules. Prolia is a monoclonal antibody that prevents bone loss by blocking a protein that breaks down bones. It is given as an injection under the skin once every 6 months. On the other hand, Tymlos is a parathyroid hormone analog that promotes bone formation by mimicking the hormone your body naturally makes. Tymlos is injected under the skin once a day and can only be used for up to 2 years due to a theoretical risk of bone cancer. Prolia requires you to take calcium and vitamin D supplements daily, while Tymlos may raise your calcium levels, so you should only take supplements if your provider says it's safe. Prolia may be used long-term as long as it continues to work for you, whereas Tymlos has not been studied for use longer than 2 years. Both medications have their own set of side effects and risks, so it's important to discuss with your provider which one is right for you.
Prolia (denosumab)
Tymlos (abaloparatide)
Prolia (denosumab)
Tymlos (abaloparatide)
Summary of Prolia vs. Tymlos
Summary for Monoclonal antibody
Prescription only
Prolia (denosumab) is an injection that's used to treat osteoporosis in adults at high risk of fracture. It's also for those at high risk of fractures from certain cancer medications. It works as a monoclonal antibody called a RANKL inhibitor to strengthen your bones. Prolia (denosumab) is a convenient option because you only need an injection every 6 months. It's injected under the skin by a healthcare professional at a medical office. Side effects include back and muscle pain. It also has a risk of causing dangerously low calcium levels.
Summary for Parathyroid hormone analog
Prescription only
Tymlos (abaloparatide) is a medication used for osteoporosis in men and postmenopausal women at high risk for breaking bones (fractures). It's given once per day as an injection under the skin. This medication can't be used for longer than 2 years because of a theoretical risk of causing bone cancer.
Indications of Prolia vs. Tymlos
Indications for
•Osteoporosis in women who've gone through menopause and at high risk of fracture